L
Lawrence P. McMahon
Researcher at Monash University
Publications - 116
Citations - 5865
Lawrence P. McMahon is an academic researcher from Monash University. The author has contributed to research in topics: Kidney disease & Dialysis. The author has an hindex of 29, co-authored 112 publications receiving 4883 citations. Previous affiliations of Lawrence P. McMahon include Monash University, Clayton campus & Royal Melbourne Hospital.
Papers
More filters
Journal ArticleDOI
Kidney disease: Improving global outcomes (KDIGO) anemia work group. KDIGO clinical practice guideline for anemia in chronic kidney disease
John J.V. McMurray,Patrick S. Parfrey,John W. Adamson,Pedro Aljama,Jeffrey S. Berns,Julia Bohlius,Tilman B. Drüeke,Fredric O. Finkelstein,Steven Fishbane,Tomas Ganz,Iain C. Macdougall,Ruth A. McDonald,Lawrence P. McMahon,Gregorio T. Obrador,Giovanni F.M. Strippoli,Günnter Weiss,Andrzej Wi¿cek +16 more
TL;DR: The 2012 Kidney Disease: Improving Global Outcomes Clinical Practice Guideline for Anemia in Chronic Kidney disease aims to provide guidance on diagnosis, evaluation, management and treatment for all CKD patients at risk of or with anemia.
Journal ArticleDOI
KDIGO Clinical Practice Guideline for Anemia in Chronic Kidney Disease
Jjv McMurray,Patrick S. Parfrey,John W. Adamson,Pedro Aljama,Jeffrey S. Berns,Julia Bohlius,Tilman B. Drüeke,Fredric O. Finkelstein,Steven Fishbane,Tomas Ganz,Iain C. Macdougall,Ruth A. McDonald,Lawrence P. McMahon,Gregorio T. Obrador,Gfm Strippoli,Günter Weiss,Andrzej Wiecek +16 more
TL;DR: The use of ESAs and other agents to treat anemia in CKD and methods for Guideline Development suggest that red cell transfusion is a viable treatment option.
Journal ArticleDOI
Iron management in chronic kidney disease: conclusions from a “Kidney Disease: Improving Global Outcomes” (KDIGO) Controversies Conference
Iain C. Macdougall,Andreas J. Bircher,Kai-Uwe Eckardt,Gregorio T. Obrador,Carol A. Pollock,Carol A. Pollock,Peter Stenvinkel,Dorine W. Swinkels,Christoph Wanner,Günter Weiss,Glenn M. Chertow,John W. Adamson,Tadao Akizawa,Stefan D. Anker,Michael Auerbach,Peter Bárány,Anatole Besarab,Sunil Bhandari,Ioav Cabantchik,Alan J. Collins,Daniel W. Coyne,Angel L.M. de Francisco,Steven Fishbane,Carlo A. J. M. Gaillard,Tomas Ganz,David Goldsmith,Chaim Hershko,Ewa A. Jankowska,Kirsten L. Johansen,Kamyar Kalantar-Zadeh,Philip A. Kalra,Bertram L. Kasiske,Francesco Locatelli,Jolanta Malyszko,Gert Mayer,Lawrence P. McMahon,Ashraf Mikhail,Elizabeta Nemeth,Amy Barton Pai,Patrick S. Parfrey,Roberto Pecoits-Filho,Simon D. Roger,Guy Rostoker,Jacques Rottembourg,Ajay K. Singh,Itzchak Slotki,Bruce Spinowitz,Der Cherng Tarng,Francesca Tentori,Jorge E. Toblli,Yusuke Tsukamoto,Nosratola D. Vaziri,Wolfgang C. Winkelmayer,David C. Wheeler,Elena Zakharova +54 more
TL;DR: An expert group was convened to assess the benefits and risks of parenteral iron, and to provide strategies for its optimal use while mitigating the risk for acute reactions and other adverse effects.
Journal ArticleDOI
Guidelines for the management of hypertensive disorders of pregnancy 2008.
Sandra Lowe,Sandra Lowe,Mark Brown,Gustaaf A. Dekker,S.P. Gatt,S.P. Gatt,Claire McLintock,Lawrence P. McMahon,George Mangos,George Mangos,M. Peter Moore,Peter Muller,Michael J. Paech,Barry N J Walters +13 more
TL;DR: In this article, the Society of Obstetric Medicine of Australia and New Zealand developed guidelines for the management of hypertensive diseases of pregnancy, which address a number of challenging areas including the definition of severe hypertension, the use of automated blood pressure monitors, definition of non-proteinuric pre-eclampsia and measuring proteinuria.
Journal ArticleDOI
Diagnosis and management of iron deficiency anaemia: a clinical update
Sant-Rayn Pasricha,Stephen Flecknoe-Brown,Stephen Flecknoe-Brown,Katrina J. Allen,Peter R. Gibson,Peter R. Gibson,Lawrence P. McMahon,Lawrence P. McMahon,John K. Olynyk,Simon D. Roger,Helen Savoia,Ramdas Tampi,Amanda Thomson,Amanda Thomson,Erica M. Wood,Erica M. Wood,Erica M. Wood,Kathryn Robinson +17 more
TL;DR: New‐generation IV products, supported by high‐quality evidence of safety and efficacy, may facilitate rapid administration of higher doses of iron, and may make it easier to integrate IV iron replacement into routine care.